APA (7th ed.) Citation

M, C., Y, L., K, B., M, M., BC, H., MJ, M., . . . A, A. (2024). Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis. JAMA neurology, 81(5), 515. https://doi.org/10.1001/jamaneurol.2024.0272

Chicago Style (17th ed.) Citation

M, Cortese, et al. "Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis." JAMA Neurology 81, no. 5 (2024): 515. https://doi.org/10.1001/jamaneurol.2024.0272.

MLA (9th ed.) Citation

M, Cortese, et al. "Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis." JAMA Neurology, vol. 81, no. 5, 2024, p. 515, https://doi.org/10.1001/jamaneurol.2024.0272.